MN
MediciNova, Inc.
MNOV · NASDAQ
$1.63 +0.62% (+$0.01)
1M +19.85%
Market Cap $79.7M
P/E Ratio -
Div. Yield -
ROE 26.51%
Bulios Fair Price
$0.89
45.4% downside
Trenutna cena
$1.63
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica MNOV trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
2/9Valuation
42 /100
Fair P/B 2.14x
P/S 86.63x
PEG N/A
Growth
0 /100
Declining Book val. growth 16.03%
Rev. growth N/A
FCF growth N/A
Profitability
17 /100
Weak FCF margin 587,172.00%
Op. margin 1,287.41%
Gross margin 42.39%
Quality
0 /100
Poor Asset turnover 0.02x
ROA 26.59%
ROIC 31.54%
Debt
100 /100
Low Current ratio 8.75x
Debt/Equity 0.00x
Net debt/EBITDA N/A
Stability
59 /100
Moderate EPS volatility 38.57%
Profitable years 0
Beta 0.62x
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o MNOV
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Yuichi Iwaki
Employees
6
Headquarters
La Jolla
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report